Type 2 diabetes Sarcopenia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetes patients over 65 years old Independent in ADL (activities of daily living)
Exclusion criteria
Exclusion criteria: Patients with frequent hypoglycemia Patients with pre-existing walking dysfunction due to cerebrovascular or neurological disease Patients participating in other clinical trials Patients with severe renal dysfunction (serum creatinine > 1.5 mg/dl) Patients with severe diabetic neuropathy Patients with other serious complications Patients who are judged to be inappropriate for the study by the physician's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Walking function (parameters obtained by analysis using motion capture technology: walking speed, stride length, range of motion and sway of each joint, etc.) | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment status of diabetes mellitus (blood glucose, HbA1c) | — |
Countries
Japan
Contacts
Kagawa University Hospital Department of Endocrinology and Metabolism